ChronoScale Holdings Corp
For the period ended May 31, 2026. Filed Aug 19, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2026 · Filed Aug 19, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Temporary Equity and Stockholders
Consolidated Statements of Temporary Equity and Stockholders' Equity
(In thousands)
| Temporary Equity(1) · Permanent Equity | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Preferred Stock · Common Stock · Additional Paid-in · Accumulated · Stockholders' Equity | |||||||||
| Shares · Amount · Shares(2) · Amount · Capital · Deficit · (Deficit) | |||||||||
| Balance as of May 31, 2024 | — | $— | 138,217 | $138 | $225,156 | $(76,412) | $148,882 | ||
| Net loss | — | — | — | — | (72,730) | (72,730) | |||
| Balance as of May 31, 2025 | — | $— | 138,217 | $138 | $225,156 | $(149,142) | $76,152 | ||
| Capital contributions from Applied Parent | — | — | — | — | 75,435 | — | 75,435 | ||
| Recapitalization adjustment resulting from reverse merger | 6 | 3,854 | — | 4 | 53,765 | — | 53,769 | ||
| Ekso Bionics Holdings, Inc. outstanding shares as of Business Combination date | — | — | 3,565 | — | — | — | — | ||
| Proceeds from the issuance of common stock, net | — | — | 1,311 | 1 | 14,999 | 15,000 | |||
| Conversion of Series B Preferred Stock to common stock | (3) | (1,955) | 356 | — | 1,955 | — | 1,955 | ||
| Accretion of Series B Preferred Stock to redemption value (deemed dividend) | — | 113 | — | — | (113) | — | (113) | ||
| Exercise of warrants | — | — | 700 | 1 | 4,451 | — | 4,452 | ||
| Equity incentive | — | — | 1,063 | 1 | 2,397 | — | 2,398 | ||
| Stock-based compensation | — | — | — | — | 1,297 | — | 1,297 | ||
| Net loss | — | — | — | — | — | (50,320) | (50,320) | ||
| Balance as of May 31, 2026 | 3 | $2,012 | 145,212 | $145 | $379,342 | $(199,462) | $180,025 | ||
(1) Refer to Note 13. Temporary Equity for additional information regarding the January 2026 Series B Preferred Stock (as defined below).
(2) In accordance with Accounting Standards Codification (“ASC”) 805, the historical stockholders’ equity of the Company prior to the Business Combination (as defined below) has been retrospectively adjusted for the equivalent number of shares received in the share exchange with the difference between the par value of these shares and the consideration reflected in Additional Paid-in Capital. Refer to Note 3. Business Combinations for additional information.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.